Role of peripheral nerve stimulation in treating chronic neuropathic pain: an international focused survey of pain medicine experts

被引:9
|
作者
Li, Alice Huai-Yu [1 ]
Bhatia, Anuj [2 ]
Gulati, Amit [3 ]
Ottestad, Einar [4 ]
机构
[1] Stanford Univ, Dept Anesthesia, Stanford, CA USA
[2] Univ Toronto, Dept Anesthesia & Pain Med, Toronto, ON, Canada
[3] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, New York, NY USA
[4] Stanford Univ, Anesthesiol & Pain Med, Sch Med, Palo Alto, CA USA
关键词
pain management; peripheral nerve injuries; spinal cord stimulation; LOW-BACK-PAIN; MANAGEMENT; ALGORITHM; BURDEN; GUIDELINES;
D O I
10.1136/rapm-2022-104073
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Interventional pain management (IPM) options for refractory neuropathic pain (NP) have recently increased with availability of peripheral nerve stimulation (PNS) equipment and expertise. Given a lack of high-quality evidence and guidelines on this topic, we sought to understand the perception of physicians with expertise in treating NP regarding IPM and the role of PNS. We emailed a survey in March 2022 to international NP experts including pain medicine physicians, researchers, and leaders of 11 professional pain societies. No representatives from vendors of PNS systems were included in the design of the survey nor as respondents. Among 24 respondents (67% of those contacted), the distal common peroneal, tibial, and sural nerves were most frequently targeted (60%) with PNS. Persistent postsurgical pain of more than 3 months was the most common indication for PNS (84%). The aggregate NP treatment algorithm in order of median rank was non-opioid medications as first line, IPM including epidural/perineural steroid injections tied with transcutaneous electrical nerve stimulation as second line, pulsed radiofrequency (RF) tied with RF ablation/denervation as third line, temporary then permanent PNS as fourth line, followed by spinal cord stimulation, opioids, cryoablation, botulinum, peripheral nerve field stimulation, intrathecal targeted drug delivery, and others. Before offering PNS, 12 respondents (50%) indicated their preference for trialing non-neuromodulation treatments for 1-3 months. Twenty-two respondents (92%) agreed PNS should be offered early in the treatment of neuropathic pain. The most common barriers to PNS use were cost, lack of high-quality evidence in support of its use, lack of exposure to PNS in training programs, and lack of familiarity with the use of ultrasound guidance. PNS appears to have an increasing role in the treatment of NP but more research is needed on the outcomes of PNS to elucidate its role.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
  • [21] Peripheral Nerve Stimulation for Neuropathic Pain Management: A Narrative Review
    Mao, Zhangyan
    Lv, Jing
    Sun, Yan
    Shen, Jiwei
    Gao, Yafen
    Sun, Shujun
    Yang, Dong
    PAIN AND THERAPY, 2024, 13 (06) : 1387 - 1406
  • [22] Peripheral nerve stimulation for the treatment of chronic pain
    Mobbs, R. J.
    Nair, S.
    Blum, P.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2007, 14 (03) : 216 - 221
  • [23] Mechanism of Peripheral Nerve Stimulation in Chronic Pain
    Lin, Tiffany
    Gargya, Akshat
    Singh, Harmandeep
    Sivanesan, Eellan
    Gulati, Amitabh
    PAIN MEDICINE, 2020, 21 : S6 - S12
  • [24] Peripheral Nerve/Field Stimulation for Chronic Pain
    Petersen, Erika A.
    Slavin, Konstantin V.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2014, 25 (04) : 789 - +
  • [25] Spinal Cord and Peripheral Nerve Stimulation Techniques for Neuropathic Pain
    de Leon-Casasola, Oscar A.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2009, 38 (02) : S28 - S38
  • [26] Peripheral nerve stimulation for the control of chronic pain
    Mawsouf, MN
    MANAGEMENT OF ACUTE AND CHRONIC PAIN: THE USE OF THE TOOLS OF THE TRADE, 2000, : 569 - 576
  • [27] The Use of Peripheral Nerve Stimulation in Conjunction with TMR for Neuropathic Pain
    Agrawal, Nikhil A.
    Gfrerer, Lisa
    Heng, Marilyn
    Valerio, Ian L.
    Eberlin, Kyle R.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2021, 9 (06) : E3655
  • [28] The Role of Levetiracetam in Treating Chronic Neuropathic Pain Symptoms
    Crawford-Faucher, Amy
    Huijon, R. Michael
    AMERICAN FAMILY PHYSICIAN, 2015, 92 (01) : 23 - 24
  • [29] Treating Diabetic Peripheral Neuropathic Pain
    Lindsay, Tammy J.
    Rodgers, Blake C.
    Savath, Vincent
    Hettinger, Kevin
    AMERICAN FAMILY PHYSICIAN, 2010, 82 (02) : 151 - 158
  • [30] International survey of current approaches to the management of neuropathic corneal pain by experts
    El Omda, Samy
    Tzoumas, Nikolaos
    Calonge, Margarita
    Figueiredo, Francisco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)